REFERENCES
- Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief 2009; (22):1–8.
- National Estimates from the Drug Abuse Warning Network. Joint Meeting of the Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committee. FDA, Gaithersburg, MD, 2008.
- Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings. DHHS Publication No. SMA 08-4343, 1-290. Rockville, MD: Department of Health and Human Services, August 14, 2008.
- White AG, Birnbaum HG, Mareva MN, Daher M, Vallow S, Schein J, Katz N. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm 2005; 11:469–479.
- Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, Schein JR, Katz NP. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: A societal perspective. Clin J Pain 2006; 22:667–676.
- Coalition Against Insurance Fraud. Prescription for Peril: How Insurance Fraud Finances Theft and Abuse of Addictive Prescription Drugs. Washington, DC: Coalition Against Insurance Fraud, August 25, 2008.
- Boyd CJ, McCabe SE, Cranford JA, Young A. Prescription drug abuse and diversion among adolescents in a southeast Michigan school district. Arch Pediatr Adolesc Med 2007; 161:276–281.
- Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2008. NIH Publication No. 09-7401. Bethesda, MD: National Institute on Drug Abuse, October 19, 2009.
- Partnership for a Drug-Free America. The Partnership Attitude Tracking Survey (PATS): Teens in Grades 7 through 12, 2005. May 16, 2006. Available at: http://www. rwjf.org/files/research/Full_Teen_Report 5-16-06.pdf.
- McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007; 102:1920–1930.
- McColl S, Sellers EM. Research design strategies to evaluate the impact of formulations on abuse liability. Drug Alcohol Depend 2006; 83(Suppl. 1):S52–S62.
- Butler SF, Fernandez KC, Chang A, Benoit C, Morey LC, Black R, Katz N. Measuring attractiveness for abuse of prescription opioids. Pain Med 2010; 11: 67–80.
- Katz N, Fernandez K, Chang A, Benoit C, Butler SF. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain 2008; 24:528–535.
- Villapiano A, Butler SF, Budman SH, Licari A, Morrison L, Lioya K, Houle B, Colucci R, Katz N. Demonstration of the Feasibility of Real-Time, Product-Specific, Prescription Opioid Abuse Surveillance: The NAVIPPRO System. Scottsdale, AZ: Annual Meeting of the College on Problems of Drug Dependence. June 20, 2006.
- Butler SF, Budman SH, Licari A, Cassidy TA, Lioy K, Dickinson J, Brownstein JS, Benneyan JC, Green TC, Katz N. National addictions vigilance intervention and prevention program (NAVIPPRO): A real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol Drug Saf 2008; 17:1142–1154.